OH2 Injection in Combination With HX008 for Melanoma.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
War on Melanoma™ Public Health & Education Campaign
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- NA
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors
- Status
- UNKNOWN
- Phase
- N/A
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Immune Profiles Evolution Under Immunotherapy for Melanoma
- Status
- RECRUITING
- Phase
- NA
Artificial Intelligence Augmented Training in Skin Cancer Diagnostics for General Practitioners
- Status
- COMPLETED
- Phase
- NA
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)
- Status
- COMPLETED
- Phase
- NA
BO-112 With Pembrolizumab in Unresectable Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
- Status
- RECRUITING
- Phase
- N/A
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2